These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 22321767)
1. Serial measurements of cardiac biomarkers in patients after allogeneic hematopoietic stem cell transplantation. Roziakova L; Bojtarova E; Mistrik M; Dubrava J; Gergel J; Lenkova N; Mladosievicova B J Exp Clin Cancer Res; 2012 Feb; 31(1):13. PubMed ID: 22321767 [TBL] [Abstract][Full Text] [Related]
2. Can we predict clinical cardiotoxicity with cardiac biomarkers in patients after haematopoietic stem cell transplantation? Roziakova L; Mistrik M; Batorova A; Kruzliak P; Bojtarova E; Dubrava J; Gergel J; Mladosievicova B Cardiovasc Toxicol; 2015 Jul; 15(3):210-6. PubMed ID: 25287586 [TBL] [Abstract][Full Text] [Related]
3. Abnormal cardiomarkers in leukemia patients treated with allogeneic hematopoietic stem cell transplantation. Roziakova L; Bojtarova E; Mistrik M; Krajcovicova I; Mladosievicova B Bratisl Lek Listy; 2012; 113(3):159-62. PubMed ID: 22428765 [TBL] [Abstract][Full Text] [Related]
4. Cardiovascular complications among hematopoietic cell transplantation survivors - the role of cardiomarkers. Harvanová Ľ; Lábska V; Bojtárová E; Hrubiško M; Bátorová A; Dúbrava J; Gergeľ J; Mladosievičová B Klin Onkol; 2022; 35(6):454-460. PubMed ID: 36513512 [TBL] [Abstract][Full Text] [Related]
5. Biochemical markers and assessment of cardiotoxicity during preparative regimen and hematopoietic cell transplantation in acute leukemia. Horacek JM; Pudil R; Tichy M; Jebavy L; Zak P; Slovacek L; Maly J Exp Oncol; 2007 Sep; 29(3):243-7. PubMed ID: 18004253 [TBL] [Abstract][Full Text] [Related]
6. Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study. Mavinkurve-Groothuis AM; Marcus KA; Pourier M; Loonen J; Feuth T; Hoogerbrugge PM; de Korte CL; Kapusta L Eur Heart J Cardiovasc Imaging; 2013 Jun; 14(6):562-9. PubMed ID: 23109647 [TBL] [Abstract][Full Text] [Related]
7. Usefulness of myocardial performance index and biochemical markers for early detection of anthracycline-induced cardiotoxicity in adults. Dodos F; Halbsguth T; Erdmann E; Hoppe UC Clin Res Cardiol; 2008 May; 97(5):318-26. PubMed ID: 18193371 [TBL] [Abstract][Full Text] [Related]
8. Are Biomarkers Predictive of Anthracycline-Induced Cardiac Dysfunction? Malik A; Jeyaraj PA; Calton R; Uppal B; Negi P; Shankar A; Patil J; Mahajan MK Asian Pac J Cancer Prev; 2016; 17(4):2301-5. PubMed ID: 27221934 [TBL] [Abstract][Full Text] [Related]
9. Assessment of anthracycline-induced cardiotoxicity with biochemical markers. Horacek JM; Pudil R; Jebavy L; Tichy M; Zak P; Maly J Exp Oncol; 2007 Dec; 29(4):309-13. PubMed ID: 18199989 [TBL] [Abstract][Full Text] [Related]
11. N-Terminal Pro B-Type Natriuretic Peptide and High-Sensitivity Cardiac Troponin T Levels Are Related to the Extent of Hibernating Myocardium in Patients With Ischemic Heart Failure. Zelt JGE; Liu PP; Erthal F; deKemp RA; Wells G; O'Meara E; Garrard L; Beanlands RSB; Mielniczuk LM Can J Cardiol; 2017 Nov; 33(11):1478-1488. PubMed ID: 28966019 [TBL] [Abstract][Full Text] [Related]
12. Elevations in High-Sensitive Cardiac Troponin T and N-Terminal Prohormone Brain Natriuretic Peptide Levels in the Serum Can Predict the Development of Anthracycline-Induced Cardiomyopathy. Bisoc A; Ciurescu D; Rădoi M; Tântu MM; Rogozea L; Sweidan AJ; Bota DA Am J Ther; 2020; 27(2):e142-e150. PubMed ID: 30648987 [TBL] [Abstract][Full Text] [Related]
13. Cardiac biomarkers indicate a need for sensitive cardiac imaging among long-term childhood cancer survivors exposed to anthracyclines. Ylänen K; Poutanen T; Savukoski T; Eerola A; Vettenranta K Acta Paediatr; 2015 Mar; 104(3):313-9. PubMed ID: 25393922 [TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics of Patients with Different N-Terminal Probrain Natriuretic Peptide Levels after Hematopoietic Stem Cell Transplantation. Se Z; Zhou H; Li H; Sun J; Zhan Q; Zeng Q; Liu Q; Xu D Dis Markers; 2020; 2020():8839336. PubMed ID: 33133305 [TBL] [Abstract][Full Text] [Related]
15. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study. Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872 [TBL] [Abstract][Full Text] [Related]
16. Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients With Stable Angina. Caselli C; Prontera C; Liga R; De Graaf MA; Gaemperli O; Lorenzoni V; Ragusa R; Marinelli M; Del Ry S; Rovai D; Giannessi D; Aguade-Bruix S; Clemente A; Bax JJ; Lombardi M; Sicari R; Zamorano J; Scholte AJ; Kaufmann PA; Knuuti J; Underwood SR; Clerico A; Neglia D Arterioscler Thromb Vasc Biol; 2016 Apr; 36(4):757-64. PubMed ID: 26868212 [TBL] [Abstract][Full Text] [Related]
17. Role of NT-proBNP in detection of myocardial damage in childhood leukemia survivors treated with and without anthracyclines. Mladosievicova B; Urbanova D; Radvanska E; Slavkovsky P; Simkova I J Exp Clin Cancer Res; 2012 Oct; 31(1):86. PubMed ID: 23057994 [TBL] [Abstract][Full Text] [Related]
18. Prognostic assessment of elderly patients with symptoms of heart failure by combining high-sensitivity troponin T and N-terminal pro-B-type natriuretic peptide measurements. Alehagen U; Dahlström U; Rehfeld JF; Goetze JP Clin Chem; 2010 Nov; 56(11):1718-24. PubMed ID: 20844063 [TBL] [Abstract][Full Text] [Related]
19. Cardiac troponin T and NT-proBNP as diagnostic and prognostic biomarkers of primary cardiac involvement and disease severity in systemic sclerosis: A prospective study. Bosello S; De Luca G; Berardi G; Canestrari G; de Waure C; Gabrielli FA; Di Mario C; Forni F; Gremese E; Ferraccioli G Eur J Intern Med; 2019 Feb; 60():46-53. PubMed ID: 30366614 [TBL] [Abstract][Full Text] [Related]
20. Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction. Demissei BG; Hubbard RA; Zhang L; Smith AM; Sheline K; McDonald C; Narayan V; Domchek SM; DeMichele A; Shah P; Clark AS; Fox K; Matro J; Bradbury AR; Knollman H; Getz KD; Armenian SH; Januzzi JL; Tang WHW; Liu P; Ky B J Am Heart Assoc; 2020 Jan; 9(2):e014708. PubMed ID: 31959034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]